U.S. Awards Contract for COVID-19 Home Test Kit
MONDAY, Feb. 1, 2021 -- The U.S. government has awarded a $231 million contract for production of a recently approved over-the-counter COVID-19 home test kit.
With the product from Australian company Ellume, users can swab themselves at home and check their status in about 20 minutes. It is one of only three consumer self-use tests and the only one available without a doctor's prescription, the Associated Press reported.
Ellume said it would use the contract to build a U.S. manufacturing plant and deliver 8.5 million tests for federal use, but the company did not give a delivery timeframe.
Health experts have long emphasized the need for fast, widespread home testing, but the vast majority of tests still require a nasal swab to be taken by a health worker and sent to a lab for processing, the AP reported.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Further Support and Information on COVID-19
Read this next
Walmart Expands COVID-19 Vaccination Program
MONDAY, March 1, 2021 -- Walmart said it will expand its COVID-19 vaccination program to more than 1,400 pharmacies in 35 states. The retailer will also partner with local...
AstraZeneca COVID-19 Vaccine Easy to Update in Response to Variants
MONDAY, March 1, 2021 -- A COVID-19 vaccine still awaiting U.S. Food and Drug Administration approval may prove to be a powerful weapon in fighting the pandemic, according to its...
J&J COVID-19 Vaccine Granted Emergency Use Authorization
MONDAY, March 1, 2021 -- The Janssen COVID-19 vaccine received the third emergency use authorization for a vaccine to prevent COVID-19, the U.S. Food and Drug Administration...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.